FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel fluorinated 1,4-naphthoquinone derivatives of general formula , where 1 R=C6H5, X=F; 2 R=2, 5-F2C6H3, X=F; 3 R=CH3, X=F; 4 R=C6H5, X, , possessing cytotoxic activity with respect to cancer cells, which can be applied in medicine.
EFFECT: claimed are novel compounds with anti-cancer activity for therapy of malignant neoplasms.
1 dwg, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
ALKYLATING FLUORINATED 1,4-NAPHTHOQUINONE DERIVATIVES HAVING CYTOTOXIC EFFECT ON HUMAN CANCER CELLS IN CULTURE | 2012 |
|
RU2499789C1 |
FLUORINATED 1,4-NAPHTHOQUINONE DERIVATIVES HAVING CYTOTOXIC EFFECT ON HUMAN CANCER CELLS IN CULTURE | 2010 |
|
RU2443678C1 |
FLUORINATED 1,4-NAPHTHOQUINONE DERIVATIVES HAVING CYTOTOXIC EFFECT ON HUMAN CANCER CELLS IN CULTURE | 2008 |
|
RU2387635C1 |
FRACTION OF DNA-HYDROLYSE SECRETORY IMMUNOGLOBULINS OF CLASS A, WITH SELECTIVE APOPTOTIC ACTIVITY IN RELATION TO HUMAN CANCER CELLS | 2015 |
|
RU2605321C1 |
LABDANE-TYPE 6-HYDROXYNAPHTHOQUINONES, HAVING CYTOTOXIC ACTIVITY ON HUMAN TUMOUR CELLS | 2012 |
|
RU2479582C1 |
DIPROPIONATE BETULIN COMPOSITION | 2013 |
|
RU2541153C1 |
(17S)-N-BENZYL-5-((3Β-ACETOXY-28-NOR-URS-12-ENE)-17-YL)-1,3,4-OXADIAZOL-2-AMINE, HAVING SELECTIVE CELL CYTOTOXICITY BREAST CANCER MCF-7 | 2019 |
|
RU2708400C1 |
RECOMBINANT PLASMID DNA pFLAG-sc14D5a-Rm7 ENSURING SYNTHESIS OF HYBRID PROTEIN sc14D5a-Rm7, BACTERIA STRAIN Escherichia coli - PRODUCER OF HYBRID PROTEIN sc14D5a-Rm7, AND HYBRID PROTEIN sc14D5a-Rm7, COMBINING PROTEIN E OF TICK-BORNE ENCEPHALITIS MICE AND HAVING BIO-LUMINESCENCE ACTIVITY | 2014 |
|
RU2565545C1 |
TRITERPENE ANTI-TUMOUR DRUG PRODUCED VIA MODIFICATION OF GLYCYRRHETIC ACID | 2009 |
|
RU2401273C1 |
METHOD OF PRODUCING 6,7-SUBSTITUTED 2,3,5,8-TETRAHYDROXY-1,4-NAPHTHOQUINONES (SPINAZARINS) | 2012 |
|
RU2478607C1 |
Authors
Dates
2014-12-20—Published
2013-08-06—Filed